BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33245947)

  • 1. Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
    Rühle A; Stromberger C; Haehl E; Senger C; David H; Stoian R; Zamboglou C; Knopf A; Budach V; Grosu AL; Nicolay NH
    Radiother Oncol; 2021 Jan; 154():276-282. PubMed ID: 33245947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
    Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nomogram and risk classification system for predicting overall survival in head and neck squamous cell cancer with distant metastasis at initial diagnosis.
    Zhu RQ; Zhang YM; Luo XY; Shen WY; Zhu HY
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1467-1478. PubMed ID: 36316576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
    Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
    Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic nomogram for long-term survival in patients with locally advanced oropharyngeal cancer after (chemo)radiotherapy.
    De Felice F; Humbert-Vidan L; Lei M; King A; Guerrero Urbano T
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1955-1961. PubMed ID: 36427081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation.
    Rühle A; Zou J; Glaser M; Halle L; Gkika E; Schäfer H; Knopf A; Becker C; Grosu AL; Popp I; Nicolay NH
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2605-2616. PubMed ID: 36764957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy.
    Rühle A; Todorovic J; Spohn SSK; Gkika E; Becker C; Knopf A; Zamboglou C; Sprave T; Werner M; Grosu AL; Kayser G; Nicolay NH
    Radiat Oncol; 2022 Nov; 17(1):181. PubMed ID: 36376922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
    Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
    Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nomograms based on immune scores for head-neck squamous cell carcinoma patients.
    Li W; Zhao K; Wang Z
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2493-2500. PubMed ID: 33068170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
    Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
    Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
    Zschaeck S; Löck S; Leger S; Haase R; Bandurska-Luque A; Appold S; Kotzerke J; Zips D; Richter C; Gudziol V; Schreiber A; Zöphel K; Baumann M; Krause M
    Radiother Oncol; 2017 Mar; 122(3):437-444. PubMed ID: 28222892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
    Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
    Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
    BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic model for overall survival of head and neck cancer patients in the palliative phase.
    Hoesseini A; Sewnaik A; van den Besselaar BN; Zhang J; van Leeuwen N; Hardillo JA; Baatenburg de Jong RJ; Offerman MPJ
    BMC Palliat Care; 2024 Feb; 23(1):54. PubMed ID: 38395897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Schüttrumpf L; Marschner S; Scheu K; Hess J; Rietzler S; Walch A; Baumeister P; Kirchner T; Ganswindt U; Zitzelsberger H; Belka C; Maihoefer C
    Radiat Oncol; 2020 Jan; 15(1):7. PubMed ID: 31906998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
    Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
    Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
    Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522.
    Awan MJ; Gittleman H; Barnholtz-Sloan J; Machtay M; Nguyen-Tan PF; Rosenthal DI; Schultz C; Huth BJ; Thorstad WL; Frank SJ; Kim H; Foote RL; Lango MN; Shenouda G; Suntharalingam M; Harris J; Zhang Q; Le QT; Yao M;
    Oral Oncol; 2021 May; 116():105241. PubMed ID: 33640577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation.
    Haehl E; Alvino L; Rühle A; Zou J; Fabian A; Grosu AL; Nicolay NH
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
    Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
    PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.